Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Letue35 

Discuss National Oilwell Varco

NOV Inc.

WKN: A2QLRE / Symbol: NOV / Name: NOV / Aktie / Öl & Gas - Ausrüstung und Service / Mid Cap /

?
-1,65 %

Einschätzung Buy
Rendite (%) 30,69 %
Kursziel 20,31
Veränderung
Endet am 15.04.26

NOV Inc. (NYSE: NOV) had its price target lowered by analysts at Stifel Nicolaus from $25.00 to $23.00. They now have a "buy" rating on the stock.
Ratings data for NOV provided by MarketBeat

Einschätzung Buy
Rendite (%) 32,57 %
Kursziel 16,71
Veränderung
Endet am 30.04.26

NOV Inc. (NYSE: NOV) had its price target lowered by analysts at Royal Bank of Canada from $20.00 to $19.00. They now have an "outperform" rating on the stock.
Ratings data for NOV provided by MarketBeat

Einschätzung Buy
Rendite (%) 32,57 %
Kursziel 14,95
Veränderung
Endet am 30.04.26

NOV Inc. (NYSE: NOV) had its price target lowered by analysts at JPMorgan Chase & Co. from $20.00 to $17.00. They now have an "overweight" rating on the stock.
Ratings data for NOV provided by MarketBeat

Einschätzung Sell
Rendite (%) 28,80 %
Kursziel 9,73
Veränderung
Endet am 01.05.26

NOV Inc. (NYSE: NOV) had its price target raised by analysts at Wells Fargo & Company from $10.00 to $11.00. They now have an "underweight" rating on the stock.
Ratings data for NOV provided by MarketBeat

Einschätzung Buy
Rendite (%) 21,74 %
Kursziel 13,39
Veränderung
Endet am 16.05.26

NOV Inc. (NYSE: NOV) had its price target lowered by analysts at Morgan Stanley from $18.00 to $15.00. They now have an "overweight" rating on the stock.
Ratings data for NOV provided by MarketBeat

Einschätzung Sell
Rendite (%) 27,90 %
Kursziel 8,76
Veränderung
Endet am 05.06.26

NOV Inc. (NYSE: NOV) had its price target lowered by analysts at Wells Fargo & Company from $11.00 to $10.00. They now have an "underweight" rating on the stock.
Ratings data for NOV provided by MarketBeat

Einschätzung Buy
Rendite (%) 24,10 %
Kursziel 15,28
Veränderung
Endet am 01.07.26

NOV Inc. (NYSE: NOV) had its price target lowered by analysts at Susquehanna from $19.00 to $18.00. They now have a "positive" rating on the stock.
Ratings data for NOV provided by MarketBeat

Einschätzung Buy
Rendite (%) 24,38 %
Kursziel 18,95
Veränderung
Endet am 16.07.26

NOV Inc. (NYSE: NOV) had its price target lowered by analysts at Stifel Nicolaus from $23.00 to $22.00. They now have a "buy" rating on the stock.
Ratings data for NOV provided by MarketBeat

Einschätzung Buy
Rendite (%) 21,44 %
Kursziel 17,29
Veränderung
Endet am 30.07.26

NOV Inc. (NYSE: NOV) had its price target lowered by analysts at Stifel Nicolaus from $22.00 to $20.00. They now have a "buy" rating on the stock.
Ratings data for NOV provided by MarketBeat

Einschätzung Buy
Rendite (%) 21,44 %
Kursziel 14,70
Veränderung
Endet am 30.07.26

NOV Inc. (NYSE: NOV) had its price target lowered by analysts at Susquehanna from $18.00 to $17.00. They now have a "positive" rating on the stock.
Ratings data for NOV provided by MarketBeat

Einschätzung Buy
Rendite (%) 19,05 %
Kursziel 15,56
Veränderung
Endet am 30.07.26

NOV Inc. (NYSE: NOV) had its price target lowered by analysts at Royal Bank Of Canada from $19.00 to $18.00. They now have an "outperform" rating on the stock.
Ratings data for NOV provided by MarketBeat

NOV (NYSE:NOV) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Ratings data for NOV provided by MarketBeat

Einschätzung Buy
Rendite (%) 4,26 %
Kursziel 16,31
Veränderung
Endet am 29.10.26

NOV (NYSE:NOV) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $19.00 price target on the stock.
Ratings data for NOV provided by MarketBeat

Einschätzung Buy
Rendite (%) 2,80 %
Kursziel 16,31
Veränderung
Endet am 29.10.26

NOV (NYSE:NOV) was given a new $19.00 price target on by analysts at Stifel Nicolaus. They now have a "buy" rating on the stock.
Ratings data for NOV provided by MarketBeat

NOV (NYSE:NOV) had its "sell" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Ratings data for NOV provided by MarketBeat